Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoadjuvant Chemoimmunotherapy × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 675 Neoplasms 606 Prostatic Neoplasms 327 Lung Neoplasms 295 Colorectal Neoplasms 268 Carcinoma, Non-Small-Cell Lung 262 Pancreatic Neoplasms 176 Carcinoma, Hepatocellular 167 Stomach Neoplasms 138 Multiple Myeloma 124 Colonic Neoplasms 119 Melanoma 117 Ovarian Neoplasms 116 Hematologic Neoplasms 111 Brain Neoplasms 106 Urinary Bladder Neoplasms 102 Leukemia, Myeloid, Acute 101 Head and Neck Neoplasms 100 Esophageal Neoplasms 95 Disease 94 Neoplasm Metastasis 92 Uterine Cervical Neoplasms 89 Lymphoma 89 Precursor Cell Lymphoblastic Leukemia-Lymphoma 84 Liver Neoplasms 84 Rectal Neoplasms 80 Endometrial Neoplasms 78 Carcinoma, Renal Cell 77 Leukemia 68 Sarcoma 63

Interventions

Robotic Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07528066 2026-04-14

DRAGON-NSCLC

Shanghai Chest Hospital

Neoadjuvant Chemoimmunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡